Long Shortz with EZZ: $21 million distribution deal with ROFA

EZZ Life Science signs a 3 year, $21 million distribution deal with ROFA Enterprises to expand its presence in Southeast Asia.

Tylah Tully chats with EZZ Life Science (ASX:EZZ) chair Glenn Cross about the three-year, $21 million distribution deal the company has signed with ROFA Enterprises to expand its presence in Southeast Asia, targeting key markets in Thailand, Vietnam, and Singapore.

The agreement marks a major milestone in EZZ’s regional growth strategy, with operations set to begin in June 2025.

Cross says the company is "very excited about the opportunity" and expects strong results similar to their success in China.

Watch the video to learn more about the company.

This video was developed in collaboration with EZZ Life Science, a Stockhead advertiser at the time of publishing. 

The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.